miglustat gen.orph
gen.orph - miglustat - gaucher sygdom - andre alimentary tract and metabolism produkter, - miglustat gen. orph er indiceret til oral behandling af voksne patienter med mild til moderat type 1 gaucher sygdom. miglustat gen. orph kan kun anvendes i behandling af patienter, for hvem enzymsubstitutionsbehandlingen er uegnet. miglustat gen. orph er indiceret til behandling af progressive neurologiske forstyrrelser hos voksne patienter, og pædiatriske patienter med niemann-picks sygdom type c.
bosentan "gen.orph" 125 mg filmovertrukne tabletter
gen-orph sas - bosentan, monohydrat - filmovertrukne tabletter - 125 mg
bosentan "gen.orph" 62,5 mg filmovertrukne tabletter
gen-orph sas - bosentan, monohydrat - filmovertrukne tabletter - 62,5 mg
buprenorphine "glenmark" 10 mikrogram/time depotplastre
glenmark arzneimittel gmbh - buprenorphin - depotplastre - 10 mikrogram/time
buprenorphine "glenmark" 20 mikrogram/time depotplastre
glenmark arzneimittel gmbh - buprenorphin - depotplastre - 20 mikrogram/time
buprenorphine "glenmark" 5 mikrogram/time depotplastre
glenmark arzneimittel gmbh - buprenorphin - depotplastre - 5 mikrogram/time
buprenorphine "sandoz" 10 mikrogram/time depotplastre
sandoz a/s - buprenorphin - depotplastre - 10 mikrogram/time
buprenorphine "sandoz" 15 mikrogram/time depotplastre
sandoz a/s - buprenorphin - depotplastre - 15 mikrogram/time
buprenorphine "sandoz" 20 mikrogram/time depotplastre
sandoz a/s - buprenorphin - depotplastre - 20 mikrogram/time
buprenorphine "sandoz" 5 mikrogram/time depotplastre
sandoz a/s - buprenorphin - depotplastre - 5 mikrogram/time